Dura Pharmaceuticals

Dura Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on the development and marketing of prescription drugs, including synthetic peptides for the treatment of allergies and asthma. The company was acquired by Elan Corporation in November 2000 for approximately $1.8 billion in a stock swap transaction.